1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Florida >
  6. RetinalGeniX Acquires DNA/GPS

M&A Deal Summary

RetinalGeniX Acquires DNA/GPS

On July 6, 2022, RetinalGeniX acquired life science company DNA/GPS

Acquisition Highlights
  • This is RetinalGeniX’s 1st transaction in the Life Science sector.
  • This is RetinalGeniX’s 1st transaction in the United States.
  • This is RetinalGeniX’s 1st transaction in Florida.

M&A Deal Summary
Date 2022-07-06
Target DNA/GPS
Sector Life Science
Buyer(s) RetinalGeniX
Deal Type Add-on Acquisition

Target

DNA/GPS

Tampa, Florida, United States
DNA/GPS is a pharmacogenetics company, that allows healthcare providers to use retinal imaging and genetic mapping to monitor and screen patients from their homes to provide diagnoses of systemic diseases including heart disease, Alzheimer’s, dementia, Parkinson's, and more. DNA/GPS is based in Tampa, Florida.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

RetinalGeniX

Apollo Beach, Florida, United States
Category Company
Founded 2017
Sector Medical Products
Revenue 2M USD (2022)
DESCRIPTION

RetinalGeniX is a medical device company focused on preventing blindness through a cost-effective Mass Retinal Screening Device and a Patient Real-Time Home Monitoring Imaging & Physician Alert System. RetinalGeniX was founded in 2017 and is based in Apollo Beach, Florida.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Florida M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2022 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal